British pharma giant GSK is heading back to school, pledging up to 50 million pounds sterling (about $62.4 million) to work ...
Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...
GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines. The University of Oxford and GSK are to work on a vaccine to target cells in the ...
Scientists are working to create a new cancer vaccine that could “detect the undetectable” and stop the disease up to 20 years before it has the chance to develop. Pharmaceutical giant GSK and ...
Pharmaceutical giant GSK and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or vaccines which target ...
The partnership intends to create a vaccine or vaccines which target cells at the pre-cancerous stage before the disease has taken hold and begun to wreak havoc on the body The University of ...
The University of Oxford and GSK are to work on a vaccine to target cells in the pre-cancerous stage (PA) Pharmaceutical giant GSK and the University of Oxford are creating a new cancer vaccine to ...
Pharmaceutical giant GSK and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or vaccines which target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback